Eucrates Biomedical Acquisition - Units (1 Ord & 1/3 War) Current Assets

As of the most recent data (December 2022), EUCRU shows a current assets of $130K. That compares with $260K in the prior-year period — down 50.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EUCRU's current assets is now $130K (was $260K) — a 50.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Eucrates Biomedical Acquisition - Units (1 Ord & 1/3 War) is outperforming or lagging.

Tracking EUCRU's current assets over time shows whether Eucrates Biomedical Acquisition - Units (1 Ord & 1/3 War) is scaling, shrinking, or reshaping that part of the business. The current reading is $130K That compares with $260K in the prior-year period — down 50.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Eucrates Biomedical Acquisition - Units (1 Ord & 1/3 War)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $130K) with ownership activity and broader fundamentals.